rodeotto
Nuovo forumer
Tuesday, October 2, 2012
Two Outperformers: Sirius XM Radio (NASDAQ
IRI) & Cell Therapeutics Inc (NASDAQ:CTIC)
[FONT="]Shares in Cell Therapeutics Inc(NASDAQ:CTIC) rose by more than a fourth after the U.S. Food and Drug Administration granted orphan status to its brain cancer drug.[/FONT]
[FONT="]
[/FONT]
[FONT="]Orphan status, is granted by the U.S. FDA to drugs that treat diseases affecting fewer than 200,000 people. It also provides seven years' marketing exclusivity from the date of approval to Cell Therapeutics.[/FONT]
[FONT="]
[/FONT]
[FONT="]Has CTIC Found The Bottom and Ready To Move Up? Find Out Here [/FONT]
[FONT="]The designation was granted based on preliminary data from the mid-stage study of the drug, Opaxio, for treating glioblastoma multiforme (GBM), the company said.[/FONT]
Two Outperformers: Sirius XM Radio (NASDAQ
![Hei, ti devo dire questa :S :S](/images/smilies/shhh.gif)
[FONT="]Shares in Cell Therapeutics Inc(NASDAQ:CTIC) rose by more than a fourth after the U.S. Food and Drug Administration granted orphan status to its brain cancer drug.[/FONT]
[FONT="]
[/FONT]
[FONT="]Orphan status, is granted by the U.S. FDA to drugs that treat diseases affecting fewer than 200,000 people. It also provides seven years' marketing exclusivity from the date of approval to Cell Therapeutics.[/FONT]
[FONT="]
[/FONT]
[FONT="]Has CTIC Found The Bottom and Ready To Move Up? Find Out Here [/FONT]
[FONT="]The designation was granted based on preliminary data from the mid-stage study of the drug, Opaxio, for treating glioblastoma multiforme (GBM), the company said.[/FONT]